Latest On-Demand Webinars

Cell and gene therapies harness the power of cells or genetic material to treat, cure or prevent diseases. These cutting-edge therapeutics have the potential to revolutionize medical treatments, especially for conditions that were previously thought to be incurable, including genetic disorders, cancer and degenerative conditions.

Meaningful biomarker studies that account for genetic, environmental and lifestyle variation, or comprise of complex signatures from multiple proteins, require large cohorts – too large for the current proteomics discovery platforms.

Dr. Yuan Liu from Indiana University will be joining Technology Networks to provide a comprehensive overview of this promising field, paving the way for potential therapeutics.

Molecular diagnostics have revolutionized healthcare by enabling accurate and efficient disease diagnosis and treatments. Aging and growing populations, increased prevalence of infectious diseases and rising costs are impacting the diagnostic landscape presenting the need for increased clinical lab efficiency and innovation.

This webinar series will delve into the intricacies of the modern clinical lab and explore ways to optimize and streamline molecular diagnostics workflows and technologies to aid in the identification and diagnosis of disease.

In this webinar, Dr. Christian Koepfli will join us to explore the many factors affecting the performance of qPCR assays and how this impacts population-based studies. He will also outline strategies on how to optimize the sensitivity of these tests to increase lab efficiency.

Join us for an exclusive opportunity to speak directly with Dr. David Baltimore, a distinguished figure in this field and a Nobel Laureate, as he navigates the complexities of CRISPR genome editing technology.

In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics.

New for 2024, our expert speaker will engage with the audience in real-time, addressing questions on various aspects of microplastics science and research .

Alzheimer’s disease (AD) is the most common form of dementia in the elderly population. While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking.

Generating a highly expressing, regulatory compliant clonal cell line is key when developing a biopharmaceutical. Yet cell line development is labor-intensive, time consuming and costly.

The production of a high-quality and productive cell line requires both an expression system which yields high expressing clones and a workflow which allows selection of the highest producing clones.

In this webinar, you’ll discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary (GS-CHO) expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.

An incredible opportunity to ask Andy Shovel, the Co-CEO of THIS absolutely anything about his career, life or the future of foods.